1 domain / 2 areas / 2 specializations
St Pancras Clinical Research
Data updated
UK site-network and SMO-style research provider with a dedicated psychedelic dosing room, controlled-drug capability, and recruitment pathways for depression, AUD, and neuropsychiatric trials.
Clinical Trial Infrastructure Snapshot
Site Networks & SMOsService Model
Hybrid
Service Coverage
1 country
Psychedelic Experience
Verified Psychedelic Trial Experience
Last Source Check
Jun 18, 2026
Public Sources
2
Lifecycle Coverage
Service Coverage Countries
Phase Coverage
Capabilities
Research Update
Public-source profile available
Last checked Jun 18, 2026 across 2 sources.
Search Finding
UK site/SMO with dedicated psychedelic dosing room, controlled-drug capability, and neuropsychiatric/depression/AUD recruitment.
Service Notes
Strong addition to Site Networks & SMOs. Use city-level catchments around verified clinics until exact site addresses are reviewed.
Linked Stakeholders
No linked stakeholders yet.
Linked Trials
A Phase 3 Trial to Assess CYB003 in Major Depressive Disorder (EMBRACE)
Recruiting
Phase 2 Clinical Trial of GH001 in Postpartum Depression
Terminated
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD (COMP 006)
Active not recruiting
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Completed
Quick Facts
- HQ
- London Clinic (city-level coordinate), United Kingdom
- Website
- Visit